Literature DB >> 29801191

Neonatal Alexander Disease: Novel GFAP Mutation and Comparison to Previously Published Cases.

Oula Knuutinen1,2,3, Maria Kousi4,5, Maria Suo-Palosaari2,6, Jukka S Moilanen1,2,7, Hannu Tuominen8, Leena Vainionpää9, Tarja Joensuu4,10,11, Anna-Kaisa Anttonen4,10,11,12, Johanna Uusimaa1,2,3,9, Anna-Elina Lehesjoki4,10,11, Päivi Vieira1,2,9.   

Abstract

Alexander disease (AxD) is a genetic leukodystrophy caused by GFAP mutations leading to astrocyte dysfunction. Neonatal AxD is a rare phenotype with onset in the first month of life. The proband, belonging to a large pedigree with dominantly inherited benign familial neonatal epilepsy (BFNE), had a phenotype distinct from the rest of the family, with hypotonia and macrocephaly in addition to drug-resistant neonatal seizures. The patient deteriorated and passed away at 6 weeks of age. The pathological and neuroimaging data were consistent with the diagnosis of AxD. Genetic analysis of the proband identified a novel de novo GFAP missense mutation and a KCNQ2 splice site mutation segregating with the BFNE phenotype in the family. The GFAP mutation was located in the coil 2B region of GFAP protein, similar to most neonatal-onset AxD cases with an early death. The clinical and neuroradiological features of the previously published neonatal AxD patients are presented. This study further supports the classification of neonatal-onset AxD as a distinct phenotype based on the age of onset. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29801191     DOI: 10.1055/s-0038-1649500

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  1 in total

1.  GFAP variant p. Tyr366Cys demonstrated widespread brain cavitation in neonatal Alexander disease.

Authors:  Hirokazu Takeuchi; Norimichi Higurashi; Hiroshi Kawame; Tadashi Kaname; Kumiko Yanagi; Yuichiro Nonaka; Tatsuya Hirotsu; Satoshi Matsushima; Tetsuya Shimizu; Taku Gomi; Nei Fukasawa
Journal:  Radiol Case Rep       Date:  2021-12-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.